Phenominer Database Results (13 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Clinical Measurement Notes Record ID Study ID
GK/Slc blood high density lipoprotein cholesterol level controlled ipragliflozin content diet (0.008 %) (for 21 days) Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. blood HDL cholesterol amount male 105.0 days 7.0 mg/dl 0.7 blood high-density lipoprotein-cholesterol measurement test 0.0 n=4-6 102897 2781
GK/Slc urine 3-hydroxybutyrate level controlled ipragliflozin content diet (0.008 %) (for 21 days) Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. urine ketone body amount male 105.0 days 1161.8 umol/l 301.9 urine analysis 0.0 n=4-6 102921 2781
GK/Slc blood free fatty acids level controlled ipragliflozin content diet (0.008 %) (for 21 days) Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. blood free fatty acid amount male 105.0 days 21.51 mg/dl 4.26 blood free fatty acid analysis 0.0 ueq/l = umol/l 102885 2781
GK/Slc blood triglyceride level controlled ipragliflozin content diet (0.008 %) (for 21 days) Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. blood triglyceride amount male 105.0 days 31.0 mg/dl 3.9 blood triglyceride analysis 0.0 n=4-6 102889 2781
GK/Slc blood creatinine level controlled ipragliflozin content diet (0.008 %) (for 21 days) Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. blood creatinine amount male 105.0 days 0.24 mg/dl 0.0 blood creatinine analysis 0.0 n=4-6 102909 2781
GK/Slc timed urine volume controlled ipragliflozin content diet (0.008 %) (for 21 days) Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. urine output male 105.0 days 29.3 ml/d 3.6 urine volume measurement method 0.0 n=4-6 102925 2781
GK/Slc urine glucose level controlled ipragliflozin content diet (0.008 %) (for 21 days) Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. urine glucose amount male 105.0 days 9401.0 mg/dl 1647.7 blood glucose test strip read by electrochemical glucometer 0.0 n=4-6 102929 2781
GK/Slc blood glycated albumin level controlled ipragliflozin content diet (0.008 %) (for 21 days) Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. blood albumin amount male 105.0 days 1.9 % 0.09 blood protein analysis 0.0 glycated albumin n=4-6 102877 2781
GK/Slc blood hemoglobin A1c level controlled ipragliflozin content diet (0.008 %) (for 21 days) Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. blood hemoglobin amount male 105.0 days 5.47 % 0.03 blood hemoglobin analysis 0.0 HbA1c n=4-6 102881 2781
GK/Slc blood total cholesterol level controlled ipragliflozin content diet (0.008 %) (for 21 days) Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. blood cholesterol amount male 105.0 days 78.8 mg/dl 3.8 blood cholesterol analysis 0.0 n=4-6 102893 2781
GK/Slc blood urea nitrogen level controlled ipragliflozin content diet (0.008 %) (for 21 days) Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. blood urea nitrogen amount male 105.0 days 16.1 mg/dl 1.0 blood urea nitrogen analysis 0.0 n=4-6 102905 2781
GK/Slc blood low density lipoprotein cholesterol level controlled ipragliflozin content diet (0.008 %) (for 21 days) Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. blood LDL cholesterol amount male 105.0 days 29.0 mg/dl 2.1 blood low-density lipoprotein-cholesterol measurement test 0.0 n=4-6 102901 2781
GK/Slc urine acetoacetate level controlled ipragliflozin content diet (0.008 %) (for 21 days) Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. urine ketone body amount male 105.0 days 321.5 umol/l 74.8 urine analysis 0.0 n=4-6 102917 2781